Semaglutide
Semaglutide Sublingual Drops
Important Disclosure: Compounded medications are not FDA-approved. They are prepared by licensed compounding pharmacies under the supervision of healthcare providers. These medications may differ in effectiveness, side effects, and risk profile compared to FDA-approved branded drugs. Only a provider can determine if a compounded version is appropriate for your care.Semaglutide is a GLP-1 receptor agonist that has been FDA-approved in certain prescription medications for weight management and type 2 diabetes. Compounded semaglutide formulations are not FDA-approved, but are prepared by licensed compounding pharmacies under strict quality standards to meet individual patient needs and may be prescribed by licensed providers when medically appropriate and prepared by licensed compounding pharmacies. Many patients choose compounded options because they may provide greater accessibility, lower cost, and more flexible dosing formats, such as injections or oral drops.
How it works
Semaglutide Sublingual Oral Drops are absorbed through the tissue under the tongue, delivering the medication directly into the bloodstream. Like injections, they mimic the GLP-1 hormone to regulate hunger and improve glucose control, but oral drops are taken daily, allowing for consistent and flexible dosing.
How to take it
Administer Semaglutide Oral Drops daily by placing the prescribed dose under the tongue. Hold the liquid there for a the recommended time to allow absorption. This easy-to-use form is ideal for patients who prefer to avoid injections and want more flexibility in their daily routine.
What are the results?
Patients using Semaglutide Sublingual Oral Drops can expect results similar to those using injectable forms.
On average, people taking GLP-1 medications like Semaglutide experience significant weight loss. Studies have shown that individuals can lose approximately 1.5% of their body weight per week when combined with a reduced-calorie diet and increased physical activity. Based on clinical trials lasting 68 weeks, patients without diabetes who took 2.4 mg/week of Semaglutide saw substantial reductions in weight. This makes Semaglutide a highly effective treatment for long-term weight management when used as prescribed.
